Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “APL”

195 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 195 results

Not applicableStudy completedNCT01146223
What this trial is testing

Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)+1 more
Children's Oncology Group 10
Large-scale testing (Phase 3)Study completedNCT00006223
What this trial is testing

Flt3L in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT05881265
What this trial is testing

Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia

Who this might be right for
APL
Shanghai Jiao Tong University School of Medicine 30
Not applicableStudy completedNCT01804101
What this trial is testing

Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
Fred Hutchinson Cancer Center 48
Large-scale testing (Phase 3)Study completedNCT00003436
What this trial is testing

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Medical Research Council 2,000
Post-approval studies (Phase 4)UnknownNCT00180128
What this trial is testing

AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

Who this might be right for
Leukemia, Promyelocytic, Acute
Technische Universität Dresden 80
Post-approval studies (Phase 4)UnknownNCT01987297
What this trial is testing

Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

Who this might be right for
Acute Promyelocytic Leukemia
Shanghai Jiao Tong University School of Medicine 738
Not applicableApproved For MarketingNCT01869803
What this trial is testing

Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more
Wake Forest University Health Sciences
Early research (Phase 1)Study completedNCT00002588
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia

Who this might be right for
Leukemia
Case Comprehensive Cancer Center 30
Not applicableLooking for participantsNCT05832320
What this trial is testing

Optimum Induction Therapy of Low-risk APL

Who this might be right for
Acute Promyelocytic LeukemiaInduction TherapyOral
Peking University People's Hospital 74
Testing effectiveness (Phase 2)Ended earlyNCT02128269
What this trial is testing

Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid (aPL)-Positive
Alexion Pharmaceuticals, Inc. 9
Large-scale testing (Phase 3)Study completedNCT00591526
What this trial is testing

Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)

Who this might be right for
Leukemia, Promyelocytic, Acute
Groupe d'etude et de travail sur les leucemies aigues promyelocytaires 250
Not applicableStudy completedNCT07203885
What this trial is testing

AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment

Who this might be right for
Acute Promyelocytic Leukemia (APL)Acute Myeloid Leukaemia (AML)
Harvard Medical School (HMS and HSDM) 10
Testing effectiveness (Phase 2)Looking for participantsNCT04793919
What this trial is testing

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica 89
Large-scale testing (Phase 3)UnknownNCT04175587
What this trial is testing

Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL

Who this might be right for
Acute Promyelocytic Leukaemia
Peking University People's Hospital 109
Large-scale testing (Phase 3)Looking for participantsNCT07503730
What this trial is testing

Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).

Who this might be right for
APL
First Affiliated Hospital Xi'an Jiaotong University 224
Testing effectiveness (Phase 2)Study completedNCT00588809
What this trial is testing

Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)Myelodysplastic Syndromes+3 more
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Study completedNCT00413166
What this trial is testing

All-trans Retinoic Acid, and Arsenic +/- Idarubicin

Who this might be right for
Acute Promyelocytic Leukemia
M.D. Anderson Cancer Center 78
Early research (Phase 1)Study completedNCT00114257
What this trial is testing

Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
National Cancer Institute (NCI) 36
Not applicableNo Longer AvailableNCT02312037
What this trial is testing

Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy

Who this might be right for
CD33 Positive Acute Myelogenous Leukemia
Pfizer
Load More Results